These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia. Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541 [TBL] [Abstract][Full Text] [Related]
3. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140 [TBL] [Abstract][Full Text] [Related]
4. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias. Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785 [TBL] [Abstract][Full Text] [Related]
6. Contrasting patterns of coronary atherosclerosis in normocholesterolaemic smokers and patients with familial hypercholesterolaemia. Sugrue DD; Thompson GR; Oakley CM; Trayner IM; Steiner RE Br Med J (Clin Res Ed); 1981 Nov; 283(6303):1358-60. PubMed ID: 6797539 [TBL] [Abstract][Full Text] [Related]
7. Treatment of familial hypercholesterolaemia. United Kingdom lipid clinics study of pravastatin and cholestyramine. Betteridge DJ; Bhatnager D; Bing RF; Durrington PN; Evans GR; Flax H; Jay RH; Lewis-Barned N; Mann J; Matthews DR BMJ; 1992 May; 304(6838):1335-8. PubMed ID: 1611329 [TBL] [Abstract][Full Text] [Related]
8. Clinical features of ischaemic heart disease correlated with high density lipoprotein cholesterol levels in men with hyperbetalipoproteinaemia. Nye ER; Robertson MC; Sutherland WH N Z Med J; 1984 Jul; 97(759):437-42. PubMed ID: 6589538 [TBL] [Abstract][Full Text] [Related]
9. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694 [TBL] [Abstract][Full Text] [Related]
10. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity. Erem C Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444 [TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia. Sebestjen M; Zegura B; Guzic-Salobir B; Keber I Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736 [TBL] [Abstract][Full Text] [Related]
12. Association of high total cholesterol with coronary heart disease mortality differs among subject populations--familial hypercholesterolemia as a key concept. Okuyama H; Ichikawa Y; Sun Y; Hamazaki T; Lands WE World Rev Nutr Diet; 2007; 96():19-36. PubMed ID: 17167278 [No Abstract] [Full Text] [Related]
13. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia. Paiker JE; Raal FJ; von Arb M Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():174-8. PubMed ID: 10735360 [TBL] [Abstract][Full Text] [Related]
14. Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association. Wray R; Neil H; Rees J J R Coll Physicians Lond; 1996; 30(2):115-8. PubMed ID: 8709055 [TBL] [Abstract][Full Text] [Related]
15. Effects of plant stanol and sterol esters on serum phytosterols in a family with familial hypercholesterolemia including a homozygous subject. Ketomaki A; Gylling H; Miettinen TA J Lab Clin Med; 2004 Apr; 143(4):255-62. PubMed ID: 15085084 [TBL] [Abstract][Full Text] [Related]
16. [Serum thromboxane B2 and prostaglandin F2 alpha in familial combined hyperlipoproteinemia and familial hypercholesterolemia]. Sziegoleit W; Wichmann T; Block HU; Taube C; Mest HJ Wien Klin Wochenschr; 1991; 103(8):227-31. PubMed ID: 1858388 [TBL] [Abstract][Full Text] [Related]
17. Coronary artery bypass surgery with arterial grafts in familial hypercholesterolemia. Kawasuji M; Sakakibara N; Fujii S; Yasuda T; Watanabe Y J Thorac Cardiovasc Surg; 2000 May; 119(5):1008-13; discussion 1013-4. PubMed ID: 10788822 [TBL] [Abstract][Full Text] [Related]
18. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes]. Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215 [TBL] [Abstract][Full Text] [Related]
19. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices]. Herrmann W; Reuter W Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524 [No Abstract] [Full Text] [Related]
20. [Lipoprotein spectrum and makeup of the individual classes in coronary arteriosclerosis with a varying lipid level in the blood plasma]. Gasilin VS; Kurdanov KhA; Perova NV; Torkhovskaia TI; Gadzhalova SI Kardiologiia; 1980 May; 20(5):42-6. PubMed ID: 7392382 [No Abstract] [Full Text] [Related] [Next] [New Search]